Physiological and Pathological Aspects of Unfolded Protein Response 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 30595
Special Issue Editor
Interests: misfolding diseases; unfolded protein response; membrane trafficking; gluten related disorders; gene expression; cell signaling; cell invasion
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Protein homeostasis, or proteostasis, is a dynamic process involving the continuous degradation and replacement of damaged proteins with newly synthesized proteins. Proteins are synthesised by ribosomes as unstructured polypeptides when, thanks to dedicated folding machinery involving high energy expenditure, the polypeptides acquire the correct three-dimensional structure. Indeed, some proteins are inherently difficult to fold and the fraction of them that remain misshapen has to be discarded. Meanwhile, some polypeptides that carry point mutations cannot be folded at all. Mutations can also affect and damage the folding machinery itself.
Accumulation of unfolded proteins activates the unfolded protein response (UPR), a signalling and transcriptional programme aimed at coping with cellular stress due to misfolding. UPR involves three ER stress sensors, namely PERK, IRE1, and ATF6, which trigger various molecular responses with the aim of reducing protein synthesis and enhancing folding and/or degradation of misfolded proteins. If these measures do not allow the stress to be overcome, the UPR activates apoptotic cell death.
Notably, a number of human diseases involve an alteration of proteostasis. The loss of important functions and/or toxic gains of function are the main mechanisms of these misfolding diseases. In the first group of diseases, misshapen proteins never reach their final destination because the ER quality control systems recognize and direct them to disposal (for example, via proteasome or autophagolysosome). In the second group, unfolded proteins aggregate and lead to cellular toxicity through different mechanisms. To date, the therapeutic options for misfolding diseases are rather limited. Pioneering studies have shown that neurodegenerative diseases can have some benefits from inhibiting or activating the UPR, depending on the specific disease. However, it is absolutely necessary to study more effective strategies to improve the quality of life of these patients.
This overview is not exhaustive but covers possible topics welcome in this Special Issue. I am confident that a number of additional aspects on human diseases involving misfolded proteins will be proposed.
Both original articles, reviews and commentaries are welcome.
Dr. Michele Sallese
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- human diseases
- protein folding machinery
- unfolded protein response
- ER associated degradation
- ER-to-lysosome-associated degradation
- toxic gain-of-function
- pathogenic pathways
- innovative therapeutic strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.